Connection
Thomas Campbell to Raltegravir Potassium
This is a "connection" page, showing publications Thomas Campbell has written about Raltegravir Potassium.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.027 |
|
|
|
-
Andrade A, Rosenkranz SL, Cillo AR, Lu D, Daar ES, Jacobson JM, Lederman M, Acosta EP, Campbell T, Feinberg J, Flexner C, Mellors JW, Kuritzkes DR. Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248. J Infect Dis. 2013 Sep; 208(6):884-91.
Score: 0.027